CAPITAL RESEARCH GLOBAL INVESTORS – BioMarin Pharmaceutical Inc. Transaction History
CAPITAL RESEARCH GLOBAL INVESTORS portfolio value:
$418.49M
portfolio value
CAPITAL RESEARCH GLOBAL INVESTORS quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.03% | 1.39K shares | 9.48M | $84.77 | 4.93M |
| Q2 2022 | share | Decrease | -47.43% | -4.45M shares | -314.81M | $82.87 | 4.93M |
| Q1 2022 | share | Decrease | -25.92% | -3.28M shares | -395.75M | $77.1 | 9.38M |
| Q4 2021 | share | Decrease | -28.19% | -4.97M shares | -244.22M | $89.08 | 12.67M |
| Q3 2021 | share | Decrease | -20.11% | -4.44M shares | -479.08M | $77.29 | 17.64M |
| Q2 2021 | share | Increase | +0.05% | 10.02K shares | 175.91M | $83.44 | 22.08M |
| Q1 2021 | share | Decrease | -0.01% | -2.59K shares | -269.11M | $75.51 | 22.07M |
| Q4 2020 | share | Increase | +0.07% | 15.69K shares | 257.52M | $87.69 | 22.07M |
| Q3 2020 | share | Decrease | -0.01% | -2.51K shares | -1.04B | $76.08 | 22.06M |
| Q2 2020 | share | Increase | +0.11% | 25.15K shares | 859.15M | $123.34 | 22.06M |
| Q1 2020 | share | Increase | +0.17% | 36.55K shares | 1.98M | $84.5 | 22.04M |
| Q4 2019 | share | Increase | +1.37% | 296.40K shares | 397.34M | $84.55 | 22.00M |
| Q3 2019 | share | Increase | +10.21% | 2.01M shares | -223.88M | $67.4 | 21.70M |
| Q2 2019 | share | Increase | +10.97% | 1.94M shares | 110.33M | $85.65 | 19.69M |
| Q1 2019 | share | Decrease | -3.03% | -555.10K shares | 18.05M | $88.83 | 17.74M |
| Q4 2018 | share | Decrease | -6.37% | -1.24M shares | -337.08M | $85.15 | 18.30M |
| Q3 2018 | share | Decrease | -9.47% | -2.04M shares | -138.39M | $96.97 | 19.54M |
| Q2 2018 | share | Increase | +0.43% | 92.28K shares | 290.99M | $94.2 | 21.59M |
| Q1 2018 | share | Decrease | -0.00% | -8 shares | -174.15M | $81.07 | 21.50M |
| Q4 2017 | share | Increase | +3.12% | 650.25K shares | -23.33M | $89.17 | 21.50M |
| Q3 2017 | share | Increase | +10.33% | 1.95M shares | 224.18M | $93.07 | 20.85M |
| Q2 2017 | share | Decrease | -3.79% | -744.73K shares | -7.92M | $90.82 | 18.89M |
| Q1 2017 | share | Increase | 0.00% | 390 shares | 97.07M | $87.78 | 19.64M |
| Q4 2016 | share | Decrease | -2.84% | -573.17K shares | -243.17M | $82.84 | 19.64M |
| Q3 2016 | share | Increase | +27.52% | 4.36M shares | 637.01M | $92.52 | 20.21M |
| Q2 2016 | share | Increase | 0.00% | 8 shares | -74.19M | $77.8 | 15.85M |
| Q1 2016 | share | Decrease | -11.87% | -2.13M shares | -576.85M | $82.48 | 15.85M |